The Need for Continued Development of Ricin Countermeasures
Ricin toxin, an extremely potent and heat-stable toxin produced from the bean of the ubiquitous Ricinus communis (castor bean plant), has been categorized by the US Centers for Disease Control and Prevention (CDC) as a category B biothreat agent that is moderately easy to disseminate. Ricin has the...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Hindawi Publishing Corporation
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3318197/ |
| id |
pubmed-3318197 |
|---|---|
| recordtype |
oai_dc |
| spelling |
pubmed-33181972012-04-25 The Need for Continued Development of Ricin Countermeasures Reisler, Ronald B. Smith, Leonard A. Review Article Ricin toxin, an extremely potent and heat-stable toxin produced from the bean of the ubiquitous Ricinus communis (castor bean plant), has been categorized by the US Centers for Disease Control and Prevention (CDC) as a category B biothreat agent that is moderately easy to disseminate. Ricin has the potential to be used as an agent of biological warfare and bioterrorism. Therefore, there is a critical need for continued development of ricin countermeasures. A safe and effective prophylactic vaccine against ricin that was FDA approved for “at risk” individuals would be an important first step in assuring the availability of medical countermeasures against ricin. Hindawi Publishing Corporation 2012 2012-03-26 /pmc/articles/PMC3318197/ /pubmed/22536516 http://dx.doi.org/10.1155/2012/149737 Text en Copyright © 2012 R. B. Reisler and L. A. Smith. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| repository_type |
Open Access Journal |
| institution_category |
Foreign Institution |
| institution |
US National Center for Biotechnology Information |
| building |
NCBI PubMed |
| collection |
Online Access |
| language |
English |
| format |
Online |
| author |
Reisler, Ronald B. Smith, Leonard A. |
| spellingShingle |
Reisler, Ronald B. Smith, Leonard A. The Need for Continued Development of Ricin Countermeasures |
| author_facet |
Reisler, Ronald B. Smith, Leonard A. |
| author_sort |
Reisler, Ronald B. |
| title |
The Need for Continued Development of Ricin Countermeasures |
| title_short |
The Need for Continued Development of Ricin Countermeasures |
| title_full |
The Need for Continued Development of Ricin Countermeasures |
| title_fullStr |
The Need for Continued Development of Ricin Countermeasures |
| title_full_unstemmed |
The Need for Continued Development of Ricin Countermeasures |
| title_sort |
need for continued development of ricin countermeasures |
| description |
Ricin toxin, an extremely potent and heat-stable toxin produced from the bean of the ubiquitous Ricinus communis (castor bean plant), has been categorized by the US Centers for Disease Control and Prevention (CDC) as a category B biothreat agent that is moderately easy to disseminate. Ricin has the potential to be used as an agent of biological warfare and bioterrorism. Therefore, there is a critical need for continued development of ricin countermeasures. A safe and effective prophylactic vaccine against ricin that was FDA approved for “at risk” individuals would be an important first step in assuring the availability of medical countermeasures against ricin. |
| publisher |
Hindawi Publishing Corporation |
| publishDate |
2012 |
| url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3318197/ |
| _version_ |
1611518810386333696 |